Key facts
| Recalling firm | Medtronic Perfusion Systems |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Octopus Evolution Tissue Stabilizer, Model TS2000 |
| Classification | Class II |
| Recall number | Z-2575-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | During the manufacturing process, Medtronic personnel identified an assembly issue where the tubing was incorrectly positioned. The short tube was attached to the bottom of the canister, and the long tube was attached to the top, contrary to the intended design. |
What consumers should do
Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Specifically, check whether the product in your possession matches the description on file with FDA -- Octopus Evolution Tissue Stabilizer, Model TS2000 -- and the recall number Z-2575-2026. If it matches, stop using or distributing it and contact Medtronic Perfusion Systems or the point of purchase for return or replacement instructions. Retailers and distributors holding affected inventory should quarantine it and follow the firm's written recall notice. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do.
What this classification means
FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote. In this case, the recalling firm is Medtronic Perfusion Systems and the affected product is described in FDA's record as: Octopus Evolution Tissue Stabilizer, Model TS2000. FDA's stated reason for the recall is: During the manufacturing process, Medtronic personnel identified an assembly issue where the tubing was incorrectly positioned. The short tube was attached to the bottom of the canister, and the long tube was attached to the top, contrary to the intended design.. The recall is tracked under FDA recall number Z-2575-2026 and carries a status of Ongoing as of the most recent FDA enforcement report. This classification reflects FDA's assessment of the product defect described above, not a prediction about any specific patient outcome. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do. Recall status can change while FDA and the recalling firm continue corrective actions, so checking the firm's own notice for the most current guidance is recommended.
Medtronic Perfusion Systems’s FDA history
Argus HQ has recorded 12 total FDA actions tied to Medtronic Perfusion Systems: 0 warning letters, 12 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What should someone who has this product do?
- Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Check the product against FDA's description (Octopus Evolution Tissue Stabilizer, Model TS2000) and recall number Z-2575-2026, then follow Medtronic Perfusion Systems's recall instructions.
- Has Medtronic Perfusion Systems had other FDA recalls or enforcement actions?
- Yes. Argus HQ has recorded 12 total FDA actions tied to Medtronic Perfusion Systems, including 12 recalls and 0 warning letters.
- What is the FDA recall number for this event?
- FDA recall number Z-2575-2026.
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medtronic Perfusion SystemsCompiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class II Recall: Octopus Evolution Tissue Stabilizer, Model TS2000 by Medtronic Perfusion Systems. Digital Empire LLC. Retrieved from https://argushq.ai/recall/fda-recall-medtronic-perfusion-systems-z-2575-2026
"FDA Class II Recall: Octopus Evolution Tissue Stabilizer, Model TS2000 by Medtronic Perfusion Systems." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/recall/fda-recall-medtronic-perfusion-systems-z-2575-2026.
Argus HQ Research. "FDA Class II Recall: Octopus Evolution Tissue Stabilizer, Model TS2000 by Medtronic Perfusion Systems." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/recall/fda-recall-medtronic-perfusion-systems-z-2575-2026.
@misc{argushq_argushq_ai_recall_fda_recall_medtronic_perfusion_systems_z_2575_2026_2026,
title = {FDA Class II Recall: Octopus Evolution Tissue Stabilizer, Model TS2000 by Medtronic Perfusion Systems},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/fda-recall-medtronic-perfusion-systems-z-2575-2026},
note = {Accessed: July 13, 2026}
}Source: FDA.gov — Recalls ↗

